Search Results 301-310 of 16742 for alt

1. Enhancing Adaptations To Exercise - Mayo Clinic

   Chronic active liver disease (AST>144 IU/L or ALT>165 IU/L); Oral warfarin group medications or history of blood clotting disorders. international normalized ...

2. A Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS) - Mayo Clinic

   ... (ALT) \>2.5 × ULN (unless due to hepatic iron deposition) * Serum bilirubin \>ULN, if the elevation is associated with clinically symptomatic ...

3. A Study Of CGM In GBM - Mayo Clinic

   AST and ALT ≤2.5 × ULN. Total bilirubin ≤1.5 × ULN. Willingness and ability to comply with CGM device use and attend dietary counseling sessions as part of ...

4. A Study Comparing Temozolomide and Selumetinib for Treating Patients with Metastatic Melanoma of the Eye - Mayo Clinic

   ... (ALT) (serum glutamate pyruvate transaminase [SGPT]) ≤ 2.5 times upper limit of normal for no concurrent liver metastases; AST(SGOT)/ALT(SGPT) ≤ 5 X ...

5. A Study Of Zorevunersen (STK-001) In Patients With Dravet Syndrome - Mayo Clinic

   ALT, AST, serum creatinine to calculate eGFR and/or platelet tests may be repeated once at each timepoint, if initial results do not meet this criterion, at ...

6. Auranofin And Sirolimus In Treating Participants With Ovarian Cancer - Mayo Clinic

   ... [ALT]) =< 3 x ULN or SGOT (AST) and SGPT (ALT) =< 5 x ULN is acceptable if liver has tumor involvement; Obtained =< 14 days prior to registration: Creatinine ...

7. A Study to Evaluate Itacitinib for Low Risk Graft-vs-Host Disease (GVHD) - Mayo Clinic

   ALT/SGPT and AST/SGOT must be < 5 x the upper limit of the normal range within 3 days prior to enrollment. Signed and dated written informed consent ...

8. Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery - Mayo Clinic

   SGPT (ALT) ≤ 3 x ULN; Creatinine ≤1.5 x ULN. Negative pregnancy test done ≤ 7 days prior to registration, for women of childbearing potential only. Patient ...

9. Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers - Mayo Clinic

   AST/ALT ≤ 3.0 x ULN. 9. Concomitant medications- Chronic concomitant treatment with strong CYP2C8 inhibitors is not allowed. Patients must discontinue the ...

10. A Study Of CA-4948 In Patients With Relapsed Or Refractory Primary Central Nervous System Lymphoma - Mayo Clinic

    Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) ≤ 2 × ULN;. Total bilirubin ≤ 1.5 × ULN or ≤3 × ULN in patients with documented ...